Search

Author/Creator Burdon, Jonathan

1. Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE). Issue 1 (January 2017)

Authors:
McElvaney, Noel G; Burdon, Jonathan; Holmes, Mark; Glanville, Allan; Wark, Peter A B; Thompson, Philip J; Hernandez, Paul; Chlumsky, Jan; Teschler, Helmut; Ficker, Joachim H; Seersholm, Niels; Altraja, Alan; Mäkitaro, Riitta; Chorostowska-Wynimko, Joanna; Sanak, Marek; Stoicescu, Paul I; Piitulai...
Journal:
Lancet
Issue:
Volume 5:Issue 1(2017)
Page Start:
51
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Quantitative disease progression model of α‐1 proteinase inhibitor therapy on computed tomography lung density in patients with α‐1 antitrypsin deficiency. (11th August 2017)

Authors:
Tortorici, Michael A.; Rogers, James A.; Vit, Oliver; Bexon, Martin; Sandhaus, Robert A.; Burdon, Jonathan; Chorostowska‐Wynimko, Joanna; Thompson, Philip; Stocks, James; McElvaney, Noel G.; Chapman, Kenneth R.; Edelman, Jonathan M.
Journal:
British journal of clinical pharmacology
Issue:
Volume 83:Number 11(2017)
Page Start:
2386
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Work‐related asthma: A position paper from the Thoracic Society of Australia and New Zealand and the National Asthma Council Australia. Issue 11 (5th October 2020)

Authors:
Hoy, Ryan; Burdon, Jonathan; Chen, Ling; Miles, Susan; Perret, Jennifer L; Prasad, Shivonne; Radhakrishna, Naghmeh; Rimmer, Janet; Sim, Malcolm R; Yates, Deborah; Zosky, Graeme
Journal:
Respirology
Issue:
Volume 25:Issue 11(2020)
Page Start:
1183
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗